Breast cancer screening

Cancer and Metastasis Reviews

Volumn 16, Issue 3-4, 1997, Pages 231-262

  Harris, Kathleen M ^a   Vogel, Victor G ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Age factors; Breast neoplasms; Mammography; Mass screening; Prevention and control

Indexed keywords

ADULT; AGE; AGED; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CARCINOMA IN SITU; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; IMAGE QUALITY; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; MASS SCREENING; PRIORITY JOURNAL; REVIEW;

EID: 0030694486     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1005893126451     Document Type: Review

References (112)

1. Salomon A: Beitrage zur Pathologie und Klinik der Mammacarcinome. Arch Kein Chir 110: 573-668, 1913
2. Warren SL: Roentgenologic study of the breast. AJR 24: 113-124, 1930
3. Gerhson-Cohen J, Strickler A: Roentgenologic examination of the normal breast. Its evaluation in demonstrating early neoplastic changes. Am J Roentgenol Radium Ther 40: 189-201, 1938
4. Gerhson-Cohen J, Ingleby H: Roentgenology of cancer of the breast: A classified pathological basis for roentgenologic criteria. Am J Roentgenol Radium Ther Nucl Med 68: 1-7, 1952
5. Egan RL: Historical Perspective in Breast Imaging Diagnosis and Morphology of Breast Disease. WB Saunders Co., Philadelphia, 1988, pp. 1-11
6. Egan RL: Experience with mammography in a tumor institution: Evaluation of 1000 cases. Radiology 75: 894-900, 1960
7. Egan RL: Fifty-three cases of carcinoma of the breast, occult until mammography. Am J Roentgenol Radium Ther Nucl Med 88: 1095-1111, 1962
8. Egan RL: Reproducibility of mammography: A preliminary report. Am J Roentgenol Ther Nucl Med 90: 356-358, 1963
9. Clark RL, Copeland MM, Egan RL: Reproducibility of the technique of mammography (Egan) for cancer of the breast. Am J Surg 109: 127-133, 1965
10. Scott WG: Mammography and the training program of the American College of Radiology. Am J Roentgenol Radium Ther Nucl Med 99 (4): 1002-1008, 1967
11. Shapiro S, Venet W, Strax P, Venet L: Evaluation of periodic breast cancer screening with mammography: Methodology and early observations. JAMA 195: 731-738, 1966
12. Gros CM: Methodologie: Symposium sur le sein. J Radiol Electrol Med Nucl 48: 638-655, 1967
13. Gold RH, Yaghmai AA, Bassett LW: The history of breast imaging. In: Diagnosis of Diseases of the Breast. WB Saunders Co., Philadelphia, 1977, pp. 3-28
14. Weiss JP, Wayrynen RE: Imaging system for low-dose mammography. J Appl Photogr Eng 2: 7-10, 1976
15. Baker LH: Breast Cancer Detection Demonstration Project: Five year summary report. CA 32: 196-225, 1982
16. Beahrs OH, Shapiro S, Smart C: Report of the working group to review the National Cancer Institute - American Cancer Society Breast Cancer Detection Demonstration Project. J Natl Cancer Inst 62: 639-698, 1979
17. Tabar L, Akerlund E, Gad A: Five-year experience with single-view mammography randomized controlled screening in Sweden. Recent results. Cancer Res 90: 105-113, 1984
18. Kimme-Smith C, Rothschild PA, Bassett LW, Gold RH, Moler C: Mammographic film processor temperature, development time, and chemistry: Effect on dose, contrast, and noise. AJR 152: 35-40, 1989
19. Thurfjell E, Taube A, Tabar L: One-versus two-view mammography screening: A prospective population-based study. Acta Radiologica 34: 340-344, 1994
20. van Dijck JA, Verbeek AL, Hendricks HJ, Holland R: One-view versus two-view mammography in baseline screening for breast cancer: A review. Br J Radiol 65: 971-976, 1992
21. Feig SA, Ehrlich SM: Estimation of radiation risk from screening mammography: Recent trends and comparison with expected benefits. Radiology 174: 638-647, 1990
22. Feig SA, Dodd GD, Hendrick RE: Mammography risks and benefits. In: Poznanski AK (ed) Radiation Protection in Medicine, Proceedings No. 14, Proceedings of the Twenty-Eighth Annual Meeting of the National Council on Radiation Protection and Measurements. Bethesda MD; National Council on Radiation Protection and Measurements, 1993, pp. 240-253
23. Kopans D: Mammography. In: Breast Imaging. JB Lippincott Co., Philadelphia, 1989, pp. 34-43
24. Bird RE: Screening mammography; Approach to interpretation and value of double reading. In: Kopans DB, Mendelson EB (eds) Syllabus: A Categorical Course of Breast Imaging. Radiological Society of North America Inc., Oak Brook, Illinois, 1995, pp. 73-76
25. Jackson V: Breast sonography. In: Diagnosis of Diseases of the Breast. WB Saunders Co., Philadelphia, 1997, pp. 185-196
26. Johns PC, Yaffe MJ: X-ray characterization of normal and neoplastic breast tissue. Phys Med Biol 32: 675-695, 1987
27. Wolfe JN: Risk for breast cancer development determined by mammographic parenchymal pattern. CA 37: 2486-2492, 1976
28. The Breast Cancer Detection Demonstration Project: End results. CA 35: 258-290, 1987
29. Burke P, Luparia E, Frigerio A, Marra V, Milani R, DiBenedetto A, Simeone F: Dosimetric and qualitative evaluations of the use of rhodium filtration in mammography. Radiol Med 88: 295-300, 1994
30. Kimme-Smith C, Wang J, DeBruhl N, Basic M, Bassett W: Mammograms obtained with rhodium vs molybdenum anodes: Contrast and dose differences. AJR 162: 1313-1317, 1994
31. Wu X, Gingold EL, Barnes GT, Tucker DM: Normalized average glandular dose in molybdenum target-rhodium filter and rhodium target-rhodium filter mammography. Radiology 193: 83-89, 1994
32. Bassett LW, Liu TH, Giuliano AE, Gold RH: The prevalence of carcinoma in palpable vs. impalpable, mammographically detected lesions. AJR 157: 21-24, 1991
33. Brinton LA, Devesa SS: Etiology and pathogenesis of breast cancer. In: Harris JR, Lippman ME, Morrow M, Hellman S (eds) Diseases of the Breast. JB Lippincott Co., Philadelphia, 1996, pp 159-168
34. Gram TT, Funkhouser E, Tabar L: Reproductive and menstrual factors in relation to mammographic parenchymal patterns among perimenopausal women. Br J Cancer 71: 647-650, 1995
35. Laya MB, Gallagher JC, Schreiman JS, Larson EB, Watson P, Weinstein L: Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. Radiology 196: 433-437, 1995
36. Cyrlak D, Wong CH: Mammographic changes in postmenopausal women undergoing hormonal replacement therapy. Am J Roentgenol 101: 1177-1183, 1993
37. Laya MB, Larson EB, Taplin SH, White E: Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography. J Natl Cancer Inst 88:643-649, 1996
38. Logan WW, Hoffman NY: Diabetic fibrous breast disease. Radiology 172: 667-670, 1989
39. Gyves-Ray KM, Adler DD: Dermatomyositis: An unusual cause of breast calcifications. Breast Dis 2: 195-201, 1989
40. Elwood EL, Cox B, Richardson AK: The effectiveness of breast cancer screening by mammography in younger women. Online J Curr Clin Trials ( Doc No 32) Feb 25, 1993
41. de Konig HJ, Boer R, Warmerdam PG, Beemsterboer PMM, van der Maas PJ: Quantitative interpretation of agespecific mortality reductions from the Swedish breast cancer-screening trials. J Natl Cancer Inst 87: 1217-1223, 1995
42. Fletcher SW, Black W, Harris R, Rimer BK, Shapiro S: Report of the International Workshop for the Screening of Breast Cancer. J Natl Cancer Inst 85: 1644-1656, 1993
43. Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontoft O: Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am 301: 187-210, 1992
44. Duffy SW, Chen HH, Tabar L, Day NE: Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase. Statistics Med 14: 1531-1543, 1995
45. Day NE: Estimating the sensitivity of a screening test. J Epidemiol Community Health 39: 364-366, 1985
46. Hurley SF, Kaldor JM: The benefits and risks of mammographic screening for breast cancer. Epidemiol Rev 14: 101-130, 1992
47. Ernster VL, Barclay J, Kerlikowske K, Grady D, Henderson IC: Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 275: 913-918, 1996
48. Feuer EJ, Wun L-M: How much of the recent rise in breast cancer incidence can be explained by increases in mammography utilization? A dynamic population model approach. Am J Epidemiol 136: 1423-1436, 1992
49. Kerlikowske K, Grady D, Barclay J, Sickles EA, Eaton A, Ernster V: Positive predictive value of screening mammography by age and family history of breast cancer. JAMA 270: 2444-2450, 1993
50. Trial of early detection of breast cancer: Description of method. Br J Cancer 44: 618-627, 1981
51. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL: Efficacy of screening mammography - A meta-analysis. JAMA 273: 149-154, 1995
52. Fletcher SW: Why question screening mammography for women in their forties? In: Jackson VP (ed) Breast Imaging. Radiologie Clinics of North America, WB Saunders Co., Philadelphia 33: 1259-1271, 1995
53. Kopans DB: Mammography screening and the controversy concerning women aged 40-49. In: Jackson VP (ed) Breast Imaging. Radiologie Clinics of North America, WB Saunders Co., Philadelphia 33: 1273-1290, 1995
54. Rimer B: Breast cancer screening. In: Harris JR, Lippman ME, Morrow M, Hellman S (eds) Diseases of the Breast, JB Lippincott Co., Philadelphia, 1996, pp. 307-322
55. Smith RA: Epidemiology of breast cancer. In: A Categorical Course in Physics: Technical Aspects of Breast Imaging (ed) Radiological Society of North America, Inc., Oak Brook, Illinois, 1993
56. Kopans DB, Moore RH, McCarthy KA, Hall DA, Hulka CA, Whitman GJ, Slanetz PJ, Halpern EF: Positive predictive value of breast biopsy performed as a result of mammography: There is no abrupt change at age 50 years. Radiology 200: 357-360, 1996
57. Kopans DB: Conventional wisdom: Observation, experience, anecdote, and science in breast imaging. AJR 162: 299-303, 1994
58. Shapiro S, Venet W, Strax P, Veneth L: Periodic Screening for Breast Cancer: The Health Insurance Plan Project and its Sequelae, 1963-1986. The Johns Hopkins University Press, Baltimore, 1988
59. Moss S, Alexander F: Presentation to the International Union Against Cancer meeting on breast cancer screening in premenopausal women in developed countries. Geneva, Switzerland, September 29-October 1, 1993
60. Tabar L, Duffy SW, Krusemo EB: Detection method, tumor size and node metastases in breast cancer diagnosed during a trial of breast cancer screening. Eur J Cancer Clin Oncol 23: 959-962, 1987
61. Smart CR: Highlights of the evidence of benefit for women aged 40-49 years from the 14-year follow-up of the Breast Cancer Detection Demonstration Project. Cancer 74: 296-300, 1994
62. Tabar L: New Swedish breast cancer detection results for women aged 40-49. Cancer 72: 1437-1448, 1993
63. Curpen BN, Sickles EA, Sollitto RA, Ominsky SH, Galvin HB, Frankel SD: The comparative value of mammographic screening for women 40-49 years old versus women 50-64 years old. AJR 164: 1099-1103, 1995
64. Chu KC, Smart CR, Tarone RE: Analysis of breast cancer mortality and stage distribution by age for the Health Insurance Plan clinical trial. J Natl Cancer Inst 80: 1125-1132, 1988
65. Kopans DB, Halperin E, Hulka CA: Statistical power in breast cancer screening trials and mortality reduction among women 40-49 years of age with particular emphasis on the National Breast Screening Study of Canada. Cancer 74: 1196-1203, 1994
66. Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V: Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA 276: 33-38, 1996
67. Tabar L, Fagerberg G, Chen HH, Duffy SW, Smart CR, Gad A, Smith RA: Efficacy of breast cancer screening by age: New results from the Swedish Two-County Trial. Cancer 75: 2507-2517, 1995
68. Duffy SW, Chen HH, Tabar L, Day NE: Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase. Stat Med 14: 1531-1543, 1995
69. Frisell J, Glas U, Hellstrom L, Somell A: Randomized mammographic screening for breast cancer in Stockholm. Breast Cancer Res Treat 8: 45-54, 1986
70. Tabar L, Faberberg G, Day NE, Holmberg L: What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast screening trial. Br J Cancer 55: 547-551, 1987
71. Moskowitz M: Guidelines for screening for breast cancer. Is a revision in order? In: Basset L (ed) Breast Imaging. Radiologie Clinics of North America. WB Saunders Co., Philadelphia 30 (1): 221-233, 1992
72. Tarone RE: The excess of patients with advanced breast cancer in young women screened with mammography in the Canadian National Breast Screening Study. Cancer 75: 997-1003, 1995
73. Yaffe MJ: Correction: Canada study. Letter to the editor. J Natl Cancer Inst 85: 94, 1993
74. Boyd NF, Jong RA, Yaffe MJ, Tritchler D, Lockwood G, Zylak CJ: A critical appraisal of the Canadian National Breast Cancer Screening Study. Radiology 189: 661-663, 1993
75. Marwick C: NCI Board votes to keep mammography guidelines. JAMA 270: 2783, 1993
76. Volkers N: NCI Replaces guidelines with statement of evidence. J Natl Cancer Inst 86: 14-15, 1994
77. Pelikan S, Moskowitz M: Effects of lead time, length bias, and false-negative assurance on screening for breast cancer. Cancer 71: 1998-2005, 1993
78. Tabar L, Fagerberg G, Chen HH, Duffy SW, Gad A: Screening for breast cancer in women aged under 50: Mode of detection, incidence, fatality, and histology. J Med Screening 2: 94-98, 1995
79. Solin LJ, Legorreta A, Schultz DJ, Zatz S, Goodman RL: The importance of mammographic screening relative to the treatment of women with carcinoma of the breast. Arch Intern Med 154: 745-752, 1994
80. Feig SA: Cost-effectiveness of annual versus biennial mammographic screening of women age 40-49 years. (Abstr RSNA). Radiology 198 (Suppl): 206, 1996
81. Lindfors KK, Rosenquist J: The cost-effectiveness of mammographic screening strategies. JAMA 274: 881-884, 1995
82. Tengs TO, Adams ME, Pliskin JS, Safran DG, Siegel JE, Weinstein MC, Graham JD: Five-hundred life-saving interventions and their cost-effectiveness. Risk Analysis 15: 369-384, 1995
83. Kattlove H, Liberati A, Keeler E, Brook RH: Benefits and costs of screening and treatment for early breast cancer -development of a basic benefit package. JAMA 273: 142-148, 1995
84. Lerman C, Trock B, Rimer BK, Boyce A, Jepson C, Engstrom PF: Psychological and behavioral implications of abnormal mammograms. Ann Intern Med 114: 657-661, 1991
85. Vogel VG, Graves DS, Vernon SW, Lord JA, Winn RJ, Peters GN: Mammographic screening of women with increased risk of breast cancer. Cancer 66: 1613-1620, 1990
86. Greenwald HP, Becker SW, Nevitt MC: Delay and non-compliance in cancer detection: A behavioral perspective for health planners. Mem Fund Q Health Soc 56: 212-230, 1978
87. Black WC, Nease RJ Jr, Tosteson ANA: Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Natl Cancer Inst 87: 720-731, 1995
88. Houn F, Elliott ML, McCrohan JL: The mammography quality standards act of 1992: History and philosophy. In: Jackson VP (ed) Breast Imaging, Radiologie Clinics of North America. WB Saunders Co., Philadelphia 33: 1059-1065, 1995
89. Khalkhali I, Cutrone JA, Mena IG, Diggles LE, Venegas RJ, Vargas HI, Jackson BL, Khalkhali S, Moss JF, Klein SA: Scintimammography: The complementary role of Tc-99m Sestamihi prone breast imaging for the diagnosis of breast carcinoma. Radiology 196: 421-426, 1995
90. Stelling CB: MR Imaging of the breast for cancer evaluation: Current status and future directions. In: Jackson VP (ed) Breast Imaging. Radiologie Clinics of North America. WB Saunders Co., Philadelphia 33: 1187-1204, 1995
91. Davis PL, Staiger MJ, Harris KM, Ganott MA, Klementaviciene J, McCarty KS Jr, Tobon H: Breast cancer measurements with magnetic resonance imaging, ultrasonography, and mammography. Breast Cancer Res Treat 37: 1-9, 1996
92. Harms SE, Flamig PD, Hesley KL, Meiches MD, Jensen RA, Evans WP, Savino DA, Wells RV: MR Imaging of the breast with rotating delivery of exitation off resonance: Clinical experiences with pathologic correlation. Radiology 187: 493-501, 1993
93. Davis PL, Julian TB, Staiger M, Harris KM, Borochovitz D, Klemenlaviciene J, McCarty KS Jr: Magnetic resonance imaging detection and wire localization of an occult breast cancer. Breast Cancer Res Treat 32: 327-330, 1994
94. Wald DS, Weinreb JC, Newstead G, Flyer M, Bose S: MS-Guided fine needle aspiration of breast lesions: Initial experience. J Comput Assist Tomogr 20 (1): 1-8, 1996
95. Feig SA, Yaffe MJ: Digital mammography, computer-aided diagnosis, and telemammography. In: Jackson VP (ed) Breast Imaging. Radiologie Clinics of North America. WB Saunders Co., Philadelphia 33: 1205-1230, 1995
96. Harris K, Good B, King J, Toma D, Gur D, Ilkhanipour Z, Staiger M, Oliver III J, Wintz P, Ganott M, Britton C, Straub W: Exploring computerized mammography reporting with feedback. Proc SPIE (International Society for Optical Engineering) Feb 16-19, Newport Beach CA, Vol. 1899, pp. 46-51, 1993
97. Thurfjell EL, Lernevall KA, Taube AA: Benefit of independent double reading in a population-based mammography screening program. Radiology 191: 241-244, 1994
98. Anderson EDC, Muir BB, Walsh JS, Kirkpatrick AE: The efficacy of double reading mammograms in breast screening. Comment. Clin Radiol 49: 248-251, 1994
99. Feig SA, Galkin BM, Muir HD: Evaluation of breast microcalcifications by means of optically magnified tissue specimen radiographs. Recent Results Cancer Res 105: 111-123, 1987
100. Moskowitz M: The predictive value of certain mammographic signs in screening for breast cancer. Cancer 51: 1007-1011, 1983
101. Feig SA: Hormonal reduction of mammographic densities: Potential effects on breast cancer risk and performance of diagnostic and screening mammography. J Natl Cancer Inst 86: 408-409, 1994
102. Fisher ER, Gregorio RM, Fisher B, Redmond C, Vellios F, Sommers SC: The pathology of invasive breast cancer. Cancer 36: 1-85, 1975
103. Chan HP, Doi K, Vyborny CJ, Schmidt RA, Metz CE, Lam KL, Ogura T, Wu YZ, MacMahon H: Improvement in radiologists' detection of clustered microcalcifications on mammograms. The potential of computer-aided diagnosis. Invest Radiol 25: 1102-1110, 1990
104. Kegelmeyer WP Jr, Pruneda JM, Bourland PD, Hillis A, Riggs MW, Nipper ML: Computer-aided mammographic screening for spiculaled lesions. Comment. Radiology 191: 331-337, 1994
105. Nishikawa RM, Giger ML, Doi K, Metz CE, Yin FF, Vyborny CJ, Schmidt RA: Effect of case selection on performance of computer-aided detection schemes. Med Phys 21: 265-269, 1994
106. Nishikawa RM, Doi K, Giger ML, Schmidt RA, Vyborny CJ, Monnier-Cholley L, Papaioannou J, Lu P: Computerized detection of clustered microcalcifications: Evaluation of performance on mammograms from multiple centers. Radiographics 15: 443-452, 1995
107. Vyborny CJ, Giger ML: Computer vision and artificial intelligence in mammography. AJR 162: 699-708, 1994
108. Bidgood WD Jr, Staab EV: Understanding and using teleradiology. Semin Ultrasound CT & MRI 13: 62-112, 1992
109. Batnitzky S, Rosenthal SJ, Siegal EL, Wetzel LH, Murphey MD, Cox GG, McMillan JH, Templeton AW, Dwyer SJ III: Teleradiology: An assessment. Radiology 177: 11-17, 1990
110. Physicians Insurers Association of America: The Breast Cancer Study. Physicians Insurers Association of America, Washington DC, 1995
111. Smart CR, Hendrick RE, Rutledge JH, Smith RA: Benefit of mammography screening in women aged 40-49: Current evidence from randomized trials. Cancer 75: 1619-1626, 1995
112. Smith RA: Screening women aged 40-49 years: Where are we today? J Natl Cancer Inst 87: 1198-1200, 1995